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Abstract: In a previous study, we used bacterial flagellin to deliver antigens such as p27 of 
Mycobacterium tuberculosis to a host immune system and obtained a potent Th1 response 
compared to those obtained with Freund’s adjuvant and DNA immunization. In the current 
study, using a POMP91B antigen of Chlamydophila abortus, a human and animal 
pathogen, as a model, we found that this antigen is unable to promote Th1 response. 
However, this antigen, unlike others, was able to induce a good Th2 response and IL-4 
production after immunization by recombinant protein in Freund’s adjuvant or in 
phosphate buffered saline. Our results suggest that immune response is not only dependent 
on the immunization adjuvant, but also dependent on the nature of antigen used. 
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1. Introduction  
 
Members of the Chlamydiaceae family can cause infections in all animal kingdoms [1]. After the 
recent reclassification of the Chlamydiae phylum, the Chlamydiaceae family has been divided into two 
genus, Chlamydia and Chlamydophila [2]. The two genus contain nine species and four of them, 
Chlamydia trachomatis,  Chlamydophila pneumoniae,  Chlamydophila psittaci and  Chlamydophila 
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abortus, can cause infections in human [3]. They are Gram-negative bacteria with intracellular growth. 
Among them, C. abortus is identified as the Serovar 1 of Chlamydia psittaci [2], which infects 
epithelial mucosal cells responsible for chlamydioses in a number of animal species. 
Infections with C. abortus cause abortions in sheep and goats. This bacteria, when transmitted to 
humans, can equally be responsible for abortions [4,5]. It has been difficult to generate a vaccine 
against C. abortus infection, since this intracellular obligate bacteria is difficult to obtain in large 
quantities.  
The POMP91B protein belongs to a group of four proteins, named Polymorphic Outer Membrane 
Proteins (POMPs), of approximately 90 kDa, present in the outer membrane of C. abortus [6]. 
Although they are present in small amounts in the bacteria, these proteins are powerfully 
immunogenic, as confirmed by serum analysis after abortion in sheep [7], or after injection of live 
bacteria to mice [8]. POMP91B possesses an N-terminal extracellular exposed region [7], responsible 
for the strong response in sheep which supported its use in an ELISA detection test [9,10]. The 
structure of this N-terminal part is composed of a Beta-barrel [11]. 
Pathogen Associated Molecular Patterns (PAMPs) are expressed only by micro-organisms and are 
recognized by eukaryotic cells through the Pattern Recognition Receptors (PRRs) of the innate 
immune system, such as the Toll-like receptors (TLRs) [12]. The interaction of PAMPs with their 
corresponding TLRs helps to identify the nature of the PAMP and to guide the adequate adaptive 
immune response [12]. Muramyl dipeptides, a major element of Freund's complete adjuvant, bacterial 
DNA, and flagellin are three PAMPs recognized by TLR2, TLR9, and TLR5, respectively. Freund’s 
adjuvant is usually used with high efficiency to amplify the immune response in experimental   
animals [13]. DNA technology has been used successfully in the vaccination of animal models against 
infection with viruses, bacteria, and parasites as well as in anti-tumor therapy, allergies and treatment 
of autoimmune diseases [14]. Salmonella flagellin was also used with partial success as an adjuvant 
and a carrier for a synthetic peptide representing a neutralizing epitope of influenza virus [15], and to 
produce antibodies against cholera toxin epitope [16]. The antibody response, systemic (IgG) or 
secreted (IgA), against flagellin was dependent on the route of immunization [17] and finally, 
immunization of mice with a fusion protein containing a flagellin-enhanced green protein was capable 
of stimulating antigen presenting cells and thus develop a specific T-cell response [18]. We previously 
used this strategy and obtained a good Th1 response against two different bacterial antigens [19,20]. 
The extracellular localization of the N-part of the POMP91B protein [7], as well as the other 
described POMPs proteins led to the belief that they might play an important immunological role 
either in diagnosis or in protection. In the present report, we examined the immune response against 
the N-terminal region of the POMP91B protein using different PAMPs as adjuvants and vectors for 
immunization and compared it with the responses obtained with P27 antigen of tuberculosis. A DNA 
plasmid encoding this region of POMP91B protein (DNA immunization) was prepared and its 
immunogenicity was compared with that of the recombinant protein (classical immunization) and with 
that of a recombinant fusion protein carried by the flagellar filament of bacteria E. coli (flagellin 
immunization).  
Here, we show that the administration of the recombinant POMP91B protein induces the strongest 
Th2-like response, as indicated by IL-4 and antibody production. In comparison with two other 
antigens, immunization with the bacteria expressing the partial POMB91B protein into their flagella is Toxins 2009, 1 
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not able to induce a strong Th1-like response, as indicated by the weak cell proliferation and IFN-γ 
production. The DNA immunization was unable to induce an antigen-specific immune response.  
Regarding the other antigens, the N-terminal part of the C. abortus POMP91B stimulates a strong 
Th2 response profile when the immunizations are done with the recombinant protein which does not 
require Freund’s adjuvant to present a good IL-4 and antibody response. In addition, this antigen is 
weaker in inducing a Th1 response, regardless of the immunization method used. 
 
2. Results 
 
2.1. Expression and purification of the N-terminal part of the POMP91B antigen in different systems  
 
The partial POMP91B recombinant protein was expressed in E. coli BL21(DE3) and purified using 
Ni-gel chromatography. The purified POMP91B protein fragment was analysed by SDS-PAGE as 
shown in Figure 1(a). For the expression of POMP91B into the flagellin of E. coli, the 5’ part of the 
pomp91B gene was cloned in frame with the fliC-trx fusion gene present on the plasmid pFliTrx. The 
gene was inserted in the unique RsrII site of the thioredoxin gene allowing directional insertion. 
Positive colonies were tested by PCR and confirmed by DNA sequencing. To control the expression of 
the new chimeric flagellin two tests were used. In the first test, cells were assayed by swarming test as 
described in the Experimental Section 4.2. Results in Figure 1(b) indicate that cells carrying the 
POMP91B hybrid flagellin were motile in semi-solid IMC medium supplemented with tryptophan. In 
the second test, tryptophan-induced cell lysates were fractionated on SDS gel, transferred to a 
membrane and probed with monoclonal anti- thioredoxin or anti-POMP91B antibodies, thus 
confirming the presence of POMP91B protein in transformed cells [Figure 1(c)].  
 
Figure 1. Construction and expression of the recombinant POMP91B protein (a) Coomasie 
blue staining of the bacterial lysates and purified recombinant N-terminal region of 
POMP91B protein expressed with His-Tag. Lanes 1 and 2: Bacterial extracts of E. coli 
BL21 (DE3) without or with IPTG induction respectively. Lane 3: purified POMP91B 
protein. Lane M: Biorad molecular weight standard. (b) Motility tests of E. coli GI809 
transformed with different constructions on IMC medium supplemented with tryptophan. 
Not transformed bacteria (A and D), bacteria transformed with the p27 gene of   
M. tuberculosis (B) and with the pomp91b gene of C. abortus (C) inserted in the FliCTrx 
fusion gene. Swarming is observed after 28 hours incubation at 28 °C in a semi-gelosed 
medium containing 0.3% motility agar. (c) Western Blot showing the expression of hybrid 
flagellin without insert in the Flagellin-thioredoxin (Lane 1), or with the partial POMP91B 
inserted in the thioredoxin (Lane 2). 
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2.2. Cellular immune response - Cell proliferation  
 
Figure 2. Proliferation of splenic cells of immunized mice. (a) Splenic cells from mice 
immunized either with flagellin modified bacteria (B), DNA plasmid containing the genes 
pomp91b or p27 of M. tuberculosis (D) or with the POMP91B or p27 recombinant proteins 
associated (P) or not (sP) with Freund's adjuvant, were incubated in vitro with or without 
10  μg/mL of purified POMP91B or p27 recombinant protein. The proliferation was 
monitored by [
3H] thymidine uptake (±standard errors) at 66 h after stimulation. Control 
groups have been immunized with non-modified bacteria (C-B), the empty pcDNA3 
plasmid (C-D) or with PBS in Freund’s adjuvant (C-P). (b) Response of splenic cells from 
mice received combined immunizations which were indicated by two letters. B/P means 
that the first immunization was with flagellin modified bacteria (B) and the following 
immunization with the protein in Freund’s adjuvant (P); D/B, D/P: the first immunization 
was with DNA then by bacteria (D/B) or protein (D/P); and P/B, the first immunization 
was with the protein then by bacteria. 
 
 
 
a 
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The cellular responses were first evaluated by measuring the proliferation of splenic cells after in 
vitro stimulation with the recombinant POMP91B protein. Proliferation was determined with a 
classical [
3H] thymidine incorporation assay. Groups of mice were divided into a subset that was 
antigen-boosted one week before the test and another subset that was not boosted. No significant 
differences in the cellular responses were observed between the two subsets (data not shown). Bacteria 
with non-modified flagellin (C-B), plasmid with no insert (C-D) and PBS (C-P) were used as negative 
controls, respectively. 
Unlike P27 antigen that was able to induce strong cellular proliferations (Figure 2 and [20]), 
especially after immunization with the recombinant bacteria having the p27 protein inserted in 
flagellin, the POMP91B antigen was unable to promote such an intense response, regardless of the 
immunization procedure used. Immunization with the bacteria (group B) gave the highest proliferation 
(93.517 cpm ± 19.254) for P27 antigen, whereas only 15.592 cpm ± 5.383 was obtained when the 
POMP91B antigen was used [Figure 2(a)]. Immunization by the recombinant protein emulsified first 
in CFA then by IFA (group P) induced a small increase in proliferation (20.544 cpm ± 3.850), but the 
levels were inferior when compared to those observed with the P27 antigen (38.023 ± 5.223). The 
weakest responses were obtained by DNA immunizations using pcDNA3 plasmid containing the 
pomp91B gene (group D), i.e., 3.795 cpm, or by the soluble protein without any adjuvant (group sP), 
i.e., 9.728 cpm. 
Combined immunizations with bacteria followed by boosts with the POMP91B protein in IFA 
(group B/P) as shown in Figure 2(b), increased the intensity of the response as compared to that 
obtained by the modified bacteria alone (15.592 cpm ± 5.383 to 30.533 cpm ± 7.574), and gave the 
strongest proliferation for this antigen, a result that is contrary to that observed with the P27 antigen 
(decrease from 93.517 cpm ± 19.254 to 62.593 cpm ± 9.590). In contrast to POMP91B, immunization 
with protein in CFA followed by immunization with the flagellin modified bacteria (group P/B) led to 
a relatively decreased response (20.544 cpm ± 3.850 to 17.693 cpm ± 3.001). DNA priming followed 
by the POMP91B protein (group D/P) or modified bacteria (group D/B) boosts also led to an increase 
in response intensity (3.795 cpm to 16.703 cpm and 11.347 cpm respectively). 
 
2.3. Cellular immune response - Recombinant protein immunization induces a Th2-like type of immune 
response  
 
To investigate the cytokine profile induced by the different immunization methods (plasmid DNA, 
recombinant protein, bacteria with modified flagellin), we measured the amount of antigen-specific 
IFN-γ and IL-4 secreted by splenic cells isolated from immunized mice. The spleens were harvested 
one week after the last injection. Cell suspensions were stimulated in vitro with the POMP91B or P27 
recombinant protein using different concentrations. The cytokine tests were performed on the cells 
supernatants after 48 hours and after one week of culture. At 48 hours a weak response was observed 
for both cytokines (data not shown). However, one week later high levels of IL-4 were secreted by 
splenic cells from the group of mice immunized by the recombinant protein emulsified in Freund’s 
complete and incomplete adjuvant [Figures 3(c) and 3(d); indeed, one of the three groups that secreted 
the highest IL-4 concentration was that of mice immunized with the plasmid and then recombinant 
protein (333 pg/mL)]. The two other groups boosted with the recombinant protein in IFA, B/P and P, Toxins 2009, 1 
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also induced a high release of IL-4 (212 and 243 pg/mL respectively). The group immunized with the 
protein alone had IL-4 concentration of 149 pg/mL. In the same conditions, P27 was unable to promote 
such a production of IL-4, and this level remains low for all other tested groups [Figures 3(c) and 
3(d)]. Cells from mice immunized by bacteria carrying the antigen POMP91B in their flagellin (B, 
D/B and P/B) produced lowest amounts of IL-4 (107, 39 and 52 pg/mL, respectively) whereas IL-4 
released by cells from mice immunized exclusively with plasmid DNA (6.5 pg/mL) is not significantly 
different from the control. 
 
Figure 3. Cytokine secretion by splenic cells of immunized mice. Splenic cells were 
stimulated in vitro by the recombinant POMP91B and p27 protein and IFN-γ (a and b) and 
IL-4 (c and d) were quantified in the supernatant after one week of culture. Results are 
presented as mean cytokine concentrations (±standard errors) compared to a standard curve 
of purified cytokines as mentioned in materials and methods. Controls and immunization 
as in Figure 2 (a and c for homogenized immunization, b and d for combined 
immunization). 
 
 
 
IFN-γ production [Figures 3(a) and 3(b)] for the POMP91B antigen was low in respect to that 
obtained with the P27 antigen. The highest response (113 pg/mL) was obtained with cells from mice 
primed with flagellin-modified bacteria and boosted with recombinant protein in IFA (B/P group). All 
other groups (P, sP, D/B, D/P, P/B) showed comparable IFN-γ levels, i.e., between 26 and 72 pg/mL, 
with the exception of the groups B and D in which IFN-γ release was completely absent. This is 
opposite to the effect of P27 antigen since the B group induced the best response [Figure 3(a)]. 
 
 
b
d c
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2.4. Antibody responses 
 
To investigate the anti-POMP91B antibodies titer in the sera of mice immunized with different 
combinations of antigens and their controls, the levels of IgM, IgG1, IgG2a, IgG2b, IgG3 and IgA 
were determined by ELISA one week after the second and the third immunizations. The optical 
densities (ODs) obtained for the four IgG isotypes, IgA, and IgM, were measured with sera diluted  
at 1/500. 
 
Figure 4. Specific anti-POMP91b and anti-p27 antibodies responses. Mice sera diluted at 
1/500 were tested in ELISA for the presence of anti-POMP91B or anti-p27 antibodies of 
the different isotypes IgG1, IgG2a, IgG2b, IgG3, IgM and IgA one week after the second 
(a and b) or the third (c and d) immunization. The results are presented as the optical 
density (±standard errors) of the different isotypes. Histograms a and c are for groups with 
homogenized immunization, b and d for groups with combined immunization. Controls 
and immunizations as in Figure 2. 
 Toxins 2009, 1 
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Similar to the cellular response, the antibody response depended on the PAMPs used during 
immunization. After the second (first boost) immunizations [Figure 4(a)], the group immunized with 
the protein in Freund’s adjuvant (P) gave the strongest antibody response; for IgG1 (O.D. = 1.130) and 
for IgG2a (O.D. = 0.702). Without Freund’s adjuvant, when the protein was in saline solution (sP), the 
response was also robust, but only for IgG1 (O.D. = 1.101) and not for IgG2a (O.D. = 0.156). 
The group immunized with flagellin modified bacteria (B) only developed a weak IgM response 
(O.D. = 0.153), and the DNA immunized group did not show any significant antibody response. The 
response obtained by group (P/B) [Figure 4(b)], primed with recombinant protein in CFA and boosted 
by the flagellin-modified bacteria showed weaker IgG2a response as compared to that observed for the 
Freund’s adjuvant group (O.D. = 0.788 and O.D. = 0.748 for IgG1 and IgG2a respectively). No 
significant responses were noted for the other groups, except for a weak IgM response in the two 
groups primed with the modified bacteria and B/P (O.D. = 0.153 and O.D. = 0.187 respectively).  
After the third immunization [Figures 4(c) and 4(d)], stronger responses were observed in all 
immunized groups. The best response was obtained in mice primed with flagellin-modified bacteria 
and boosted with the protein emulsified in incomplete Freund’s adjuvant (B/P) [Figure 4(d)], i.e.,  
O.D. = 2.554 for IgG2a, 2.018 for IgG2b and 1.903 for IgG1. Three other groups (P, D/P and P/B) 
present similarly weaker antibody isotype response with the highest response with IgG2a, followed by 
IgG2b and then IgG1. The order of intensity was different with the P27 antigen since the IgG2b was 
dominant, followed by IgG2a and then by IgG1. On the contrary to the P27 antigen, in these four 
groups POMP91B promoted IgG3 responses. In the group primed and boosted with the flagellin-
modified bacteria (B), IgM was the only significant immunoglobulin (O.D. = 0.780). This is similar to 
the group boosted by the flagellin-modified bacteria after priming with DNA (D/B) (O.D. = 0.722). No 
significant augmentation of any isotype could be detected in sera from mice immunized with the DNA 
plasmid for the POMP91B antigen, in contrast to the effect of P27 where IgG2a could be observed. 
Mice in the sP group gave a strong IgG1 response (O.D. = 2.370) [Figure 4(c)] but has also a good 
IgG2a response (O.D. = 1.905) that is not seen with the P27 antigen. IgA responses were negligible 
regardless of the nature of the antigen used for immunization. 
 
3. Discussion 
 
Two conclusions may be drawn from our results; first the difference between the two immune 
responses (i.e., Th1 vs. Th2) is determined by the nature of antigen, and the second concerns the 
difficulty in obtaining a cellular immune response against the POMP91B antigen of the obligate 
intracellular growth pathogen Chlamydophila abortus. 
Using different PAMPs including bacterial flagellin which is recognized by TLR5, Freund’s 
adjuvant which contains muramyl dipeptides and lipoarabinomannans, the ligand of the TLR2, and the 
CpG DNA recognized by the TLR9, we studied the immune response against the N-terminal part of the 
POMP91B protein of Chlamydophila abortus, which was found to be strongly immunogenic [7]. Then 
we compared them with those obtained in the same conditions with the p27 PPE antigen, a cell surface 
protein from M. tuberculosis [20]. Unlike the p27 PPE antigen that induced a strong proliferative 
response accompanied by high production of IFN-γ and low amount of IL-4, the POMP91B antigen 
induced in general a Th2-like response, with weak proliferation of cells, low production of IFN-γ and Toxins 2009, 1 
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high levels of IL-4. This is particularly true when immunizations are practised with the recombinant 
protein (Figures 2 and 3). The results indicated that this antigen may be involved in the establishment 
of the host humoral immune response against C. abortus. However, variations were observed in the 
intensity of the responses depending on the method of immunization used. While with p27 the 
strongest proliferative response of splenic cells in our experimental conditions was obtained utilizing 
the flagellin immunization, POMP91B antigen was not able to induce such a strong response and a 
better response was only obtained by immunization with the recombinant POMP91B antigen with 
incomplete Freund’s adjuvant after priming with flagellin-modified bacteria. In addition, the highest 
amount of IFN-γ production was found in cells derived from mice immunized using the same 
combination. It is interesting to note that for POMP91B, as for p27, the group that showed the best cell 
proliferation was also producing the highest amount of IFN-γ. IFN-γ is one of the cytokine known to 
be important in promoting a Th1 response and enhancing cytotoxicity during the priming and 
maturation of lymphocytes [22].  
In our experiments, the proliferation response induced by DNA immunization was the lowest and 
the production of IFN-γ was not significantly different from the control. The pcDNA3 plasmid used as 
the immunization vector contains two GACpGTT motifs, which are known to induce Th1 cytokines in 
mice [23,24]. However, a synergistic effect was observed between DNA vaccination and flagellin 
expression vector [25]. 
The results with POMP91B are also different from our previous observation concerning the 
immune response to Clostridium tyrobutyricum flagellin, in which a good cellular and antibody 
response were obtained using the flagellin as carrier and adjuvant [19]. The absence of IFN-γ 
production using the POMP91B antigen and the dominance of Th2 like response were also observed 
with another antigen, the Major Outer Membrane Protein (MOMP) of C. trachomatis using another 
immunization system in which murine dentritic cells were pulsed with the antigen [26]. These 
observations showing that surface proteins of Chlamydia genus do not seem to induce a CD4+ Type1 
response could be the reason for the failure to produce the needed vaccine to prevent infections. It is 
evident that IFN-γ is an important effector cytokine, particularly in the clearance of infections caused 
by human strains [27,28]. 
Despite the absence of a strong cellular response with POMP91B antigen, the role of flagellin in the 
induction of cellular responses could be clearly demonstrated by the use of combined immunizations. 
Cells isolated from mice primed by the antigen presented on the modified flagellin and boosted with 
protein in IFA released the highest amount of IFN-γ [Figure 3(b)].  
In conclusion, we found that the administration of recombinant bacteria carrying the P27 PPE 
M. tuberculosis antigen resulted in the induction of Th1 response. This kind of response may play a 
key role in protection against intracellular pathogens. Unfortunately, this immunization did not give 
such a good response with the POMP91B C. abortus antigen; however, both are cell surface exposed 
bacterial antigens. These results suggest that the nature of the antigen could influence the Th1-Th2 
balance of the immune response. Only the three-dimensional structure of the extracellular N-terminal 
part of POMP91B was determined and it represented a compact beta-helical domain with six   
rungs [11]. Combined immunization can be useful to obtain a global response (antibody and cytokine 
production). Indeed using POMP91B antigen, the best global response was observed in the group Toxins 2009, 1 
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primed by flagellin-modified bacteria that was then boosted by the recombinant protein in incomplete 
Freund’s adjuvant [Figures 2(b), 3(b), 3(d) and 4(d)].  
Concerning the humoral response to POMP91B in recombinant protein form with Freund’s 
adjuvant, the fact that the major antibody isotype primed is IgG2a, is quite surprising since this isotype 
is promoted by a Th1-like response. However, when the POMP91B antigen is injected in saline (sP) 
without any adjuvant, the IgG1 isotype of the Th2-like response is the one showing the strongest 
intensity. Here again, the study of the antibody responses confirmed our previous observations 
showing that the flagellin and the DNA system of immunization were unable to induce a good 
antibody response. In contrast, the optimal response resulted from the classical method using Freund’s 
adjuvant. For the flagellin immunization, the major isotype found in the sera was the IgM. The 
interaction of flagellin with the immune cells in our experiments failed to lead to an isotype switch. 
 
4. Experimental Section  
 
4.1. Bacterial strains, plasmid and antigens preparation 
 
Escherichia coli strains DH5α (Invitrogen, San Diego, CA, USA) and BL21 (DE3) (Novagen, San 
Diego, CA, USA) were used for cloning and overexpression of the recombinant protein, respectively. 
For the production of recombinant protein, the 5’part of the pomp91B gene was amplified by PCR 
from an original template plasmid provided by Dr. Olivier Grépinet (INRA Tours, Nouzilly, France) 
using oligonucleotide pair 5’-GGG AAT TCC ATA TGA AAC ATC CAG TCT ACT GGT T-3’ and 
5’-CGC GGA TCC GGA CGG TGT TTG TAA CGT A-3’. The oligonucleotide
 primers (Eurogentec, 
Seraing, Belgium) contained a NdeI and a BamHI site (underlined) respectively. PCR products were 
purified, digested by the two restriction enzymes NdeI and BamHI and ligated during 16 h at 4 °C with 
T4 ligase (Eurogentec) into the expression vector pET15b (Novagen) pre-digested with NdeI and 
BamHI. This plasmid encodes six histidines tagged to the N-terminus of the expressed recombinant 
protein to be purified. Expression of the recombinant protein was induced by adding 1 mM isopropyl-
β-D-thiogalactopyranoside (IPTG) to BL21(DE3) bacteria (OD600  =  0.6) carrying the recombinant 
pET-15b-pomp91b plasmid in 2 × TY medium at 28 °C for 3 to 4 hours. The bacteria were harvested 
by centrifugation, resuspended and lysed by incubation for 1 hour in lysis buffer (100 mM Na2HPO4, 
10 mM Tris-HCl, 8 M urea, pH 8.0). After centrifugation (10,000 g, 30 min), the supernatant was 
added to a Ni-NTA resin (Qiagen, Hilden, Germany). The mixture was incubated for 1 h at room 
temperature. After two washes with the same buffer, recombinant proteins were eluted with urea 8 M 
at pH of 5.9, then 4.5. The purified recombinant proteins were renatured by dialysis against PBS pH 
7.4 at 4 °C, quantified by a Bradford assay, filtered, and stored in the same buffer at -20 °C. 
For DNA immunization, the gene encoding the N-part of the POMP91B protein was cloned in the 
eukaryotic expression vector pcDNA3 (Invitrogen). Plasmid DNA was amplified in E. coli DH5α, 
purified by Qiagen purification kit, dissolved in phosphate-buffered saline (PBS), and stored at -20 °C 
until use.  
For immunizations with the bacteria carrying the POMP91B protein in their flagellin FliC protein, a 
plasmid (pFliTrx) coding for fliC gene and a specific E. coli flagellin-deficient strain were used as 
described [21]. The plasmid pFliTrx, carries the incomplete E. coli fliC coding sequence in which the Toxins 2009, 1 
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coding region for amino-acid residues 244–351 of the E. coli flagellin has been replaced, in frame, 
with the entire coding sequence for the E. coli thioredoxin (trxA) gene. The partial pomp91b gene was 
cloned in the trxA gene at the unique RsrII restriction site. The two primers used (5’-GGG GGG GTC 
CGA AAC ATC CAG TCT ACT GGT-3’ and 5’-GGG GGG GAC CGG ACG GTG TTT GTA ACG 
TA-3’) have an AvaII restriction site (underlined) allowing a directional cloning. Plasmid constructs 
were then used to transform the non-motile E. coli GI809 strain [21], which carries a specific 512 bp 
deletion within the flagellin gene (fliC, GenBank accession #M14358). Transformed motile bacteria 
were assessed for motility by swarming assay and by western blotting using specific antibodies, before 
preparation of immunization solutions. 
 
4.2. Swarming assays 
 
Non-motile E. coli GI809 cells were transformed by a flagellin containing pFliTrx plasmid and 
placed in a Petri dish containing IMC semi-gelosed medium with an agar specific for motility (Difco, 
Detroit, MI, USA) at 0.3%. The incubation was realized at 28 °C and the motility was observed at least 
15 h after the start of the culture. 
 
4.3. SDS-PAGE and western blot analysis  
 
Purified proteins and bacterial extracts were heated 5 min at 100 °C in the lysis buffer (50 mM Tris, 
pH 8.0,
  150  mM NaCl, 4% SDS, 5% β-mercaptoethanol) and electrophoresed through a 12.5% 
polyacrylamide gel, transferred
 to nitrocellulose membranes, then blotted with anti-POMP91B or anti-
thioredoxin antibodies as described in Le Moigne et al. [19]. 
 
4.4. Animals and immunization 
 
Adult female BALB/c mice (Janvier, Le Genest, France) were divided in groups of six mice and 
immunized either with 50 μg of plasmid DNA carrying the antigen coding sequence, in 100 μL PBS, 
three times with one month interval in the quadriceps muscle (DNA immunization), with 25 μg of 
antigen emulsified in complete Freund's adjuvant (CFA, containing  the H37Ra, ATCC 25177 M. 
tuberculosis strain) for the first immunization or incomplete Freund's adjuvant (IFA) for the two 
following immunizations, by a subcutaneous route (Classical immunization), with 50 μg of antigen in 
PBS (Soluble antigen) or with 10
8 modified E. coli bacteria which express the antigen into the flagellin 
at the surface of the bacteria given intraperitonneally (Flagellin immunization). Control mice for DNA 
immunization were immunized with empty pcDNA3 plasmid, whereas control mice for classical 
immunization and soluble antigen immunization were immunized with PBS incorporated in Freund's 
adjuvant or PBS alone, respectively. For the flagellin immunization, control mice were immunized 
with non modified E. coli (bacteria which express normal flagellin). Combined immunizations 
between the different methods were applied as in Table 1.  
 Toxins 2009, 1 
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Table 1. Group’s name in function of the different immunization practiced *. 
* Control animals have received PBS or no related protein mixed with CFA for classical immunization (C/P), 
empty pcDNA3 or pcDNA3 containing no related gene for DNA immunization (C/D) and normal E. coli or 
E. coli expressing no related proteins in their flagellin for bacterial immunization (C/B). 
 
Blood samples were collected one week after the last immunization from the retro-orbital plexus 
and sera were stored at −20 °C until use. All animal experiments were done in accordance with 
institutional and national ethical guidelines. 
 
4.5. Enzyme-linked immunosorbent assay (ELISA) 
 
Plates coated overnight at 4 °C with 1 µg/mL of recombinant proteins in 100 µL of carbonate-
bicarbonate buffer (0.1 M, pH 9.6), were washed with phosphate-buffered saline-Tween 20 (PBS-T) 
(0.05%; v/v) and blocked for one hour at 37 °C with PBS-T containing 0.5% gelatin (PBS-T-G). Then 
serum dilutions (1/500) in the same buffer were added. After 1 h of incubation at 37 °C and four 
washes, goat anti-mouse IgM, IgG1, IgG2a, IgG2b, IgG3 and IgA alkaline phosphatase-conjugate 
(Southern biotechnology, Birmingham, AL, USA) were added and the plates were incubated for 
another 1 h at 37 °C. After four washes, 100 µL of 1 mg/mL of p-nitrophenylphosphate (Sigma, Saint 
Quentin Fallavier, France) in diethanolamine buffer (pH 9.8) was added, and then plates were read at 
405 nm with a Titertek Multiscan instrument (Skatron, Oslo, Norway).  
 
4.6. Proliferation assay 
 
To check the effect of antigen boosting in our system, only half of the mice were boosted 
intraperitonneally with 25 μg of soluble antigen in PBS six months after the first immunization. One 
week later, splenic cells (5 × 10
5 cells/well) from antigen-boosted or non-boosted mice were 
suspended in RPMI-10% (FCS) and plated in 96-well flat bottomed plates containing serial dilution of 
antigen. Two days later, 0.5 µCi of [
3H] thymidine was added to each well and incubated for an 
additional 18 hours, then cells were harvested and thymidine incorporation was measured using a 
liquid scintillation spectrophotometer Packard 1600 Tricarb (Packard, Downers Grove, IL, USA). 
 
   Method of immunization 
  
 
Classical 
Immunization. 
DNA  
Immunization 
Flagellin  
Immunization 
First 
immunization     
Soluble 
protein  Protein + CFA  Eukaryotic plasmid  Modified bacteria 
Following 
Immunizations 
Soluble 
protein 
Protein 
+ IFA 
Bacteria Protein  + 
IFA 
Bacteria Plasmid Protein 
+ IFA 
Bacteria 
Group’s name  sP  P/P  P/B  D/P  D/B  D/D  B/P  B/B Toxins 2009, 1 
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4.7. Cytokine production and quantification by ELISA 
 
Splenic cells (5 × 10
5 cells) from boosted, non-boosted and control mice were cultured in RPMI-
10% fetal calf serum (FCS) at 37 °C in 5% CO2 in 96-well plates containing different concentrations: 
0, 1.1, 3.3 and 10 µg of recombinant proteins per mL. Supernatants were harvested after 48 h and one 
week of incubation and stored at -20 °C until use. IL-4 and IFN-γ contents were measured with a 
commercial ELISA kit (Bender MedSystems, Vienna, Austria) according to the manufacturer’s 
protocol. 
 
5. Conclusions  
 
Our results indicate that the protective immune response to an antigen depends on many factors 
including the vector, the adjuvant and the nature of the antigen. One or more of these elements may 
work for large spectre of antigens but not for all. In this case, different ways of immunizations should 
be combined to obtain a good immune response. 
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